A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02226198 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia (HoFH)

Interventions

DRUG: Rosuvastatin 20mg
DRUG: Placebo

Sponsor

AstraZeneca